Karyopharm Therapeutics Inc note 3.000%10/1 shares owned by Context Capital Management
Quarter-by-quarter ownership of Karyopharm Therapeutics Inc note 3.000%10/1 shares owned by Context Capital Management
from 13F filings
Historical chart of Context Capital Management investment in Karyopharm Therapeutics Inc note 3.000%10/1
Tip: Access up to 7 years of quarterly data
All positions including Karyopharm Therapeutics Inc note 3.000%10/1 held by Context Capital Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Karyopharm Therapeutics Inc note 3.000%10/1 by Context Capital Management
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-12-31 | $11B | 22M | 500.00 |
| 2023-09-30 | $13M | 22k | 620.13 |
| 2023-06-30 | $14M | 22k | 665.12 |
| 2023-03-31 | $15M | 19k | 775.23 |
| 2022-12-31 | $10M | 13k | 758.88 |
| 2022-09-30 | $11M | 13k | 815.18 |
| 2022-06-30 | $5.1M | 7.0k | 725.57 |
| 2022-03-31 | $14M | 17k | 833.47 |
| 2021-12-31 | $13M | 17k | 792.04 |
| 2021-09-30 | $9.6M | 13k | 752.60 |
| 2021-06-30 | $13M | 13k | 1003.00 |
| 2021-03-31 | $11M | 11k | 1036.48 |
More positions owned by Context Capital Management
View all positions for Context Capital Management
Top funds holding Karyopharm Therapeutics Inc note 3.000%10/1
View all funds holding Karyopharm Therapeutics Inc note 3.000%10/1